Singular Genomics Systems, Inc. (OMIC): Price and Financial Metrics
GET POWR RATINGS... FREE!
OMIC Stock Price Chart Interactive Chart >
OMIC Price/Volume Stats
| Current price | $4.02 | 52-week high | $27.73 |
| Prev. close | $3.82 | 52-week low | $2.66 |
| Day low | $3.64 | Volume | 316,800 |
| Day high | $4.07 | Avg. volume | 483,314 |
| 50-day MA | $3.50 | Dividend yield | N/A |
| 200-day MA | $8.43 | Market Cap | 283.75M |
Singular Genomics Systems, Inc. (OMIC) Company Bio
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. It manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits; and offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics and proteomics in one integrated instrument providing a versatile multiomics solution. The company was incorporated in 2016 and is headquartered in La Jolla, California.
Latest OMIC News From Around the Web
Below are the latest news stories about Singular Genomics Systems Inc that investors may wish to consider to help them evaluate OMIC as an investment opportunity.
16 unloved stocks ripe for a rally: Bank of AmericaThese IPO stocks look very oversold, argues Bank of America strategists. |
Singular Genomics Systems (OMIC) presents at 40th JPMorgan Annual Healthcare Conference (Slideshow)No summary available. |
Singular Genomics Partners with Lexogen to Enable RNA Library Prep for the G4 Sequencing PlatformThis partnership integrates G4’s accuracy, speed, flexibility and power with Lexogen’s expertise in RNA library preparation kits to empower specialized workflows for customers.LA JOLLA, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced a partnership with Lexogen to demonstrate the G4 sequencing platform’s compatibil |
Singular Genomics Partners with Dovetail Genomics to Enable Dovetail Kits for the G4 Sequencing PlatformThis partnership integrates G4’s accuracy, speed, flexibility and power with Dovetail’s expertise in 3-D genome architecture to empower specialized workflows for customers.LA JOLLA, Calif, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced a partnership with Dovetail Genomics to validate its proximity ligation kit portfolio, |
Singular Genomics Partners with Watchmaker Genomics to Enable the Watchmaker DNA Library Prep Kits for the G4 Sequencing PlatformThis partnership integrates G4’s accuracy, speed, flexibility and power with the Watchmaker DNA Library Prep Kits to empower innovative workflows for customersLA JOLLA, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced a partnership with Watchmaker Genomics to validate its Watchmaker DNA Library Prep Kits with Fragm |
OMIC Price Returns
| 1-mo | 17.20% |
| 3-mo | -36.39% |
| 6-mo | -66.75% |
| 1-year | -85.45% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -65.22% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
Loading social stream, please wait...